Search

everythinglearnresearchcommunity

for

Search:↓

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

Finasteride and minoxidil work best together for hair loss.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Some alternative treatments for hair loss might work, but more research is needed.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.